Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South Korea Dry Age Related Macular Degeneration Market

ID: MRFR/LS/43215-HCR
200 Pages
Vikita Thakur
Last Updated: April 06, 2026

South Korea Dry Age-Related Macular Degeneration (AMD) Market Research Report By Stage (early age-related macular degeneration, intermediate age-related macular degeneration, late age-related macular degeneration), By Age Group (above 75 years, above 60 years, above 40 years), By Diagnosis and Treatment (treatment, diagnosis), By Route of Administration (oral, injectables) and By End Users (hospitals clinics, diagnostic centers, academic research institutes) -Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South Korea Dry Age Related Macular Degeneration Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. EXECUTIVE SUMMARY
    1. Market Overview
    2. Key Findings
    3. Market Segmentation
    4. Competitive Landscape
    5. Challenges and Opportunities
    6. Future Outlook
  2. MARKET INTRODUCTION
    1. Definition
    2. Scope of the study
    3. Research Objective
    4. Assumption
    5. Limitations
  3. RESEARCH METHODOLOGY
    1. Overview
    2. Data Mining
    3. Secondary Research
    4. Primary Research
    5. Primary Interviews and Information Gathering Process
    6. Breakdown of Primary Respondents
    7. Forecasting Model
    8. Market Size Estimation
    9. Bottom-Up Approach
    10. Top-Down Approach
    11. Data Triangulation
    12. Validation
  4. MARKET DYNAMICS
    1. Overview
    2. Drivers
    3. Restraints
    4. Opportunities
  5. MARKET FACTOR ANALYSIS
    1. Value chain Analysis
    2. Porter's Five Forces Analysis
    3. Bargaining Power of Suppliers
    4. Bargaining Power of Buyers
    5. Threat of New Entrants
    6. Threat of Substitutes
    7. Intensity of Rivalry
    8. COVID-19 Impact Analysis
    9. Market Impact Analysis
    10. Regional Impact
    11. Opportunity and Threat Analysis
  6. South Korea Dry Age-Related Macular Degeneration (AMD) South Korea Dry Age Related Macular Degeneration Market, BY Stage (USD Million)
    1. early age-related macular degeneration
    2. intermediate age-related macular degeneration
    3. late age-related macular degeneration
  7. South Korea Dry Age-Related Macular Degeneration (AMD) South Korea Dry Age Related Macular Degeneration Market, BY Age Group (USD Million)
    1. above 75 years
    2. above 60 years
    3. above 40 years
  8. South Korea Dry Age-Related Macular Degeneration (AMD) South Korea Dry Age Related Macular Degeneration Market, BY Diagnosis and Treatment (USD Million)
    1. treatment
    2. diagnosis
  9. South Korea Dry Age-Related Macular Degeneration (AMD) South Korea Dry Age Related Macular Degeneration Market, BY Route of Administration (USD Million)
    1. oral
    2. injectables
  10. South Korea Dry Age-Related Macular Degeneration (AMD) South Korea Dry Age Related Macular Degeneration Market, BY End Users (USD Million)
    1. hospitals clinics
    2. diagnostic centers
    3. academic research institutes
    4. Competitive Landscape
    5. Overview
    6. Competitive Analysis
    7. Market share Analysis
    8. Major Growth Strategy in the Dry Age-Related Macular Degeneration (AMD) Market
    9. Competitive Benchmarking
    10. Leading Players in Terms of Number of Developments in the Dry Age-Related Macular Degeneration (AMD) Market
    11. Key developments and growth strategies
    12. New Product Launch/Service Deployment
    13. Merger Acquisitions
    14. Joint Ventures
    15. Major Players Financial Matrix
    16. Sales and Operating Income
    17. Major Players RD Expenditure. 2023
    18. Company Profiles
    19. Bayer
    20. Financial Overview
    21. Products Offered
    22. Key Developments
    23. SWOT Analysis
    24. Key Strategies
    25. Zeiss
    26. Financial Overview
    27. Products Offered
    28. Key Developments
    29. SWOT Analysis
    30. Key Strategies
    31. Hector Pharmaceuticals
    32. Financial Overview
    33. Products Offered
    34. Key Developments
    35. SWOT Analysis
    36. Key Strategies
    37. Roche
    38. Financial Overview
    39. Products Offered
    40. Key Developments
    41. SWOT Analysis
    42. Key Strategies
    43. VIVUS
    44. Financial Overview
    45. Products Offered
    46. Key Developments
    47. SWOT Analysis
    48. Key Strategies
    49. Ophthotech
    50. Financial Overview
    51. Products Offered
    52. Key Developments
    53. SWOT Analysis
    54. Key Strategies
    55. Alcon
    56. Financial Overview
    57. Products Offered
    58. Key Developments
    59. SWOT Analysis
    60. Key Strategies
    61. Pfizer
    62. Financial Overview
    63. Products Offered
    64. Key Developments
    65. SWOT Analysis
    66. Key Strategies
    67. Kowa Company
    68. Financial Overview
    69. Products Offered
    70. Key Developments
    71. SWOT Analysis
    72. Key Strategies
    73. Novartis
    74. Financial Overview
    75. Products Offered
    76. Key Developments
    77. SWOT Analysis
    78. Key Strategies
    79. Santen Pharmaceutical
    80. Financial Overview
    81. Products Offered
    82. Key Developments
    83. SWOT Analysis
    84. Key Strategies
    85. HoffmannLa Roche
    86. Financial Overview
    87. Products Offered
    88. Key Developments
    89. SWOT Analysis
    90. Key Strategies
    91. Eyenovia
    92. Financial Overview
    93. Products Offered
    94. Key Developments
    95. SWOT Analysis
    96. Key Strategies
    97. Regeneron Pharmaceuticals
    98. Financial Overview
    99. Products Offered
    100. Key Developments
    101. SWOT Analysis
    102. Key Strategies
    103. Appendix
    104. References
    105. Related Reports
    106. LIST Of tables
  11. LIST OF ASSUMPTIONS
  12. South Korea Dry Age-Related Macular Degeneration (AMD) Market SIZE ESTIMATES & South Korea Dry Age Related Macular Degeneration Market, BY STAGE, 2019-2035 (USD Billions)
  13. South Korea Dry Age-Related Macular Degeneration (AMD) Market SIZE ESTIMATES & South Korea Dry Age Related Macular Degeneration Market, BY AGE GROUP, 2019-2035 (USD Billions)
  14. South Korea Dry Age-Related Macular Degeneration (AMD) Market SIZE ESTIMATES & South Korea Dry Age Related Macular Degeneration Market, BY DIAGNOSIS AND TREATMENT, 2019-2035 (USD Billions)
  15. South Korea Dry Age-Related Macular Degeneration (AMD) Market SIZE ESTIMATES & South Korea Dry Age Related Macular Degeneration Market, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)
  16. South Korea Dry Age-Related Macular Degeneration (AMD) Market SIZE ESTIMATES & South Korea Dry Age Related Macular Degeneration Market, BY END USERS, 2019-2035 (USD Billions)
    1. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    2. ACQUISITION/PARTNERSHIP
    3. LIST Of figures
  17. MARKET SYNOPSIS
    1. SOUTH KOREA DRY AGE-RELATED MACULAR DEGENERATION (AMD) MARKET ANALYSIS BY STAGE
    2. SOUTH KOREA DRY AGE-RELATED MACULAR DEGENERATION (AMD) MARKET ANALYSIS BY AGE GROUP
    3. SOUTH KOREA DRY AGE-RELATED MACULAR DEGENERATION (AMD) MARKET ANALYSIS BY DIAGNOSIS AND TREATMENT
    4. SOUTH KOREA DRY AGE-RELATED MACULAR DEGENERATION (AMD) MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    5. SOUTH KOREA DRY AGE-RELATED MACULAR DEGENERATION (AMD) MARKET ANALYSIS BY END USERS
    6. KEY BUYING CRITERIA OF DRY AGE-RELATED MACULAR DEGENERATION (AMD) MARKET
    7. RESEARCH PROCESS OF MRFR
    8. DRO ANALYSIS OF DRY AGE-RELATED MACULAR DEGENERATION (AMD) MARKET
    9. DRIVERS IMPACT ANALYSIS: DRY AGE-RELATED MACULAR DEGENERATION (AMD) MARKET
    10. RESTRAINTS IMPACT ANALYSIS: DRY AGE-RELATED MACULAR DEGENERATION (AMD) MARKET
    11. SUPPLY / VALUE CHAIN: DRY AGE-RELATED MACULAR DEGENERATION (AMD) MARKET
  18. DRY AGE-RELATED MACULAR DEGENERATION (AMD) South Korea Dry Age Related Macular Degeneration Market, BY STAGE, 2024 (% SHARE)
  19. DRY AGE-RELATED MACULAR DEGENERATION (AMD) South Korea Dry Age Related Macular Degeneration Market, BY STAGE, 2019 TO 2035 (USD Billions)
  20. DRY AGE-RELATED MACULAR DEGENERATION (AMD) South Korea Dry Age Related Macular Degeneration Market, BY AGE GROUP, 2024 (% SHARE)
  21. DRY AGE-RELATED MACULAR DEGENERATION (AMD) South Korea Dry Age Related Macular Degeneration Market, BY AGE GROUP, 2019 TO 2035 (USD Billions)
  22. DRY AGE-RELATED MACULAR DEGENERATION (AMD) South Korea Dry Age Related Macular Degeneration Market, BY DIAGNOSIS AND TREATMENT, 2024 (% SHARE)
  23. DRY AGE-RELATED MACULAR DEGENERATION (AMD) South Korea Dry Age Related Macular Degeneration Market, BY DIAGNOSIS AND TREATMENT, 2019 TO 2035 (USD Billions)
  24. DRY AGE-RELATED MACULAR DEGENERATION (AMD) South Korea Dry Age Related Macular Degeneration Market, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
  25. DRY AGE-RELATED MACULAR DEGENERATION (AMD) South Korea Dry Age Related Macular Degeneration Market, BY ROUTE OF ADMINISTRATION, 2019 TO 2035 (USD Billions)
  26. DRY AGE-RELATED MACULAR DEGENERATION (AMD) South Korea Dry Age Related Macular Degeneration Market, BY END USERS, 2024 (% SHARE)
  27. DRY AGE-RELATED MACULAR DEGENERATION (AMD) South Korea Dry Age Related Macular Degeneration Market, BY END USERS, 2019 TO 2035 (USD Billions)
    1. BENCHMARKING OF MAJOR COMPETITORS

South Korea Dry Age-Related Macular Degeneration (AMD) Market Segmentation

Dry Age-Related Macular Degeneration (AMD) South Korea Dry Age Related Macular Degeneration Market By Stage (USD Million, 2019-2035)

early age-related macular degeneration

intermediate age-related macular degeneration

late age-related macular degeneration

Dry Age-Related Macular Degeneration (AMD) South Korea Dry Age Related Macular Degeneration Market By Age Group (USD Million, 2019-2035)

above 75 years

above 60 years

above 40 years

Dry Age-Related Macular Degeneration (AMD) South Korea Dry Age Related Macular Degeneration Market By Diagnosis and Treatment (USD Million, 2019-2035)

treatment

diagnosis

Dry Age-Related Macular Degeneration (AMD) South Korea Dry Age Related Macular Degeneration Market By Route of Administration (USD Million, 2019-2035)

oral

injectables

Dry Age-Related Macular Degeneration (AMD) South Korea Dry Age Related Macular Degeneration Market By End Users (USD Million, 2019-2035)

hospitals clinics

diagnostic centers

academic research institutes

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓